TrialCardiovascular diabetology2014

DPP-4 inhibitor and alpha-glucosidase inhibitor equally improve endothelial function in patients with type 2 diabetes: EDGE study.

Kazufumi Nakamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.